Sijia Cai

Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering by NetApp, Inc. of $750 million aggregate principal amount of its 1.875%…

Davis Polk advised Aptiv PLC in connection with a $1.1 billion SEC-registered offering of 15,149,519 ordinary shares (which included 1,976,024 ordinary shares that the underwriters…

Davis Polk advised the sales agents in connection with an SEC-registered at-the-market offering by Alector, Inc. of shares of its common stock for up to a maximum offering price of …

Davis Polk advised Morgan Stanley in connection with its SEC-registered global offering of $3 billion aggregate principal amount of fixed-to-floating-rate senior notes due 2026. During the…

Davis Polk advised Mitsubishi UFJ Lease & Finance Company Limited on its Rule 144A/Regulation S offering of senior notes, which consisted of $450 million aggregate principal amount of 3…

Davis Polk advised Morgan Stanley in connection with its SEC-registered global offering of $3 billion aggregate principal amount of fixed-to-floating-rate senior notes due 2031. During the…

Davis Polk advised the sole underwriter in connection with a $5.0 billion SEC-registered notes offering by NVIDIA Corporation, consisting of $1.5 billion aggregate principal amount of…

Davis Polk advised Morgan Stanley in connection with its SEC-registered global offering of $2 billion aggregate principal amount of fixed-to-floating rate senior notes due 2051. During the…

Davis Polk advised the underwriters in connection with an initial public offering of 16,100,000 shares of common stock of Revolution Medicines, Inc. at $17.00 per share (which includes the…

Davis Polk advised the underwriters in connection with the $148.5 million public offering of ordinary shares by Theravance Biopharma, Inc. Theravance Biopharma’s ordinary shares…